AbbVie Inc. against Lonza Group AG — live side-by-side technical comparison.
Prices as of 2026-10-09T20:01:20+00:00 UTC · updates daily
ABBV leads 4 of the 5 windows we measure — over 1 month ABBV is +10.2% and LONN.SW +6.4%; over year to date ABBV is +21.0% and LONN.SW +6.4%.
| ABBV | LONN.SW | |
|---|---|---|
| Price | $276.47 | $572.20 |
| 1 day | +1.5% | +1.6%lead |
| 5 days | +5.2%lead | +1.2% |
| 1 month | +10.2%lead | +6.4% |
| 6 months | +30.2%lead | +13.0% |
| Year to date | +21.0%lead | +6.4% |
| 52-week position | 99% of range | 82% of range |
| 52-week range | $190.75–$277.60 | $454.60–$597.80 |
| vs 50-day average | above $258.89 | above $567.17 |
| vs 200-day average | above $232.65 | above $532.37 |
| RSI (14) | 73 | 61 |
| Next earnings | 2026-10-30 | 2026-01-28 |
ABBV trades at $276.47, above its 50-day average of $258.89, and above the 200-day at $232.65. It sits at 99% of its 52-week range ($190.75–$277.60); 14-day RSI is 73, in overbought territory; an average session moves it about 2.1%. For levels, the first level overhead is $300.00 (8.5% away) and the first support below is $275.00 (0.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
LONN.SW trades at $572.20, above its 50-day average of $567.17, and above the 200-day at $532.37. It sits at 82% of its 52-week range ($454.60–$597.80); 14-day RSI is 61, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $580.40 (1.4% away) and the first support below is $567.17 (0.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
LONN.SW is the more volatile of the two — an average session moves it 2.4% against 2.1% for ABBV, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: ABBV clearing $300.00 or losing $275.00; LONN.SW clearing $580.40 or losing $567.17. Until one of them gives way, the relative reading above stands.